Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An update from Kamada ( (IL:KMDA) ) is now available.
On March 11, 2026, Kamada’s board declared a cash dividend of $0.25 per ordinary share, totaling about $14.4 million, under its newly adopted annual cash dividend policy. The payout was initially scheduled for April 6, 2026, to shareholders of record as of March 23, 2026, but the company has now moved the payment date to April 7, 2026, with all other terms unchanged.
The technical one-day postponement of the dividend date has no stated impact on the total distribution, signaling that Kamada remains committed to returning capital to shareholders according to its new dividend framework. The announcement underscores Kamada’s efforts to position itself as a predictable dividend payer, which may appeal to income-focused investors tracking the company’s financial policy and cash-return practices.
The most recent analyst rating on (IL:KMDA) stock is a Buy with a ILs3049.00 price target. To see the full list of analyst forecasts on Kamada stock, see the IL:KMDA Stock Forecast page.
More about Kamada
Kamada Ltd., based in Rehovot, Israel, is a biopharmaceutical company that reports as a foreign private issuer in the U.S. capital markets. The company’s shares are listed for trading in the United States, and it operates under Israeli corporate governance while complying with U.S. securities regulations and disclosure requirements.
Average Trading Volume: 86,235
Technical Sentiment Signal: Strong Buy
Current Market Cap: ILs1.58B
For an in-depth examination of KMDA stock, go to TipRanks’ Overview page.